Bortrac 2 mg The injection contains bortezomib, which is a proteasome inhibitor used in the treatment of certain types of cancers, most commonly multiple myeloma and mantle cell lymphoma. Bortezomib acts by preventing the breakdown of proteins by cell structures called proteasomes, which causes a buildup of proteins in cancer cells and ultimately results in their death.

Before using Bortrac 2 Injection, speak with your doctor if you have problems with your heart, liver, kidneys, or bleeding. It is not advised to use effective contraception when pregnant or nursing, but it is necessary throughout therapy.
 Bortrac 2 mg The injection contains bortezomib, which is a proteasome inhibitor used in the treatment of certain types of cancers, most commonly multiple myeloma and mantle cell lymphoma. Bortezomib acts by preventing the breakdown of proteins by cell structures called proteasomes, which causes a buildup of proteins in cancer cells and ultimately results in their death.

Mechanism of Action:

Proteases are important in the breakdown of proteins that control cell development, and boratezomib suppresses their action. Protease inhibition causes damaged proteins to accumulate in the cell, which kills cancer cells and slows the growth of tumors.

Uses:

• Multiple Myeloma
• Mantle Cell Lymphoma
• Waldenström's Macroglobulinemia
• Amyloidosis
  
  

  How to use this medication?

  Bortezomib is available as a liquid solution that can be injected subcutaneously (beneath the skin) or into a vein. In a clinic or doctor's office, a nurse or doctor administers boratezamib. The disease you have, the other medications you take, and how well your body reacts to treatment will all affect your dose plan.
  
  

  Throughout your therapy, make sure to let your doctor know how you are feeling. If you have side effects from bortezomib, your doctor may temporarily halt your therapy or lower your dosage.